Year: 2025
LOS ANGELES, March 12, 2025 (GLOBE NEWSWIRE) — Big Screen Entertainment Group (OTC: BSEG) is making a bold expansion into the booming beauty industry—an ever-growing global market projected to exceed $700 billion by 2028.
The Los Angeles-based film and television company has completed filming on the pilot episode of a beauty-focused TV show, seamlessly integrating a new line of cutting-edge beauty products backed by top industry experts. This venture marks a strategic expansion for Big Screen, leveraging its entertainment expertise to enter one of the most profitable consumer sectors.
While the name of the series and details of the product line remain confidential for now, audiences can expect a blend of Hollywood glamour and transformative beauty experiences featuring a lineup of well-known faces.
Among them is celebrated actress Kelli...
Form 8.3 – [THRUVISION GROUP PLC – 11 03 2025] – (CGAML)
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
THRUVISION GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date...
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2024 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Net sales for the year ended December 31, 2024 were $57.8 million, down 5.5% compared to $61.2 million for the year ended December 31, 2023
Net income for the year ended December 31, 2024 was $3.9 million, or $0.35 per diluted share, compared to $4.2 million, or $0.35 per diluted share, for the year ended December 31, 2023
Cash of $18.6 million and working capital of $47.5 million with no debt, as of December 31, 2024NOGALES, Ariz., March 12, 2025 (GLOBE NEWSWIRE) — Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced financial results for the three month period and full year, ended December 31, 2024.
Lloyd Hoffman, President and Chief Executive Officer of Alpha Pro Tech,...
Diana Shipping Inc. Announces Time Charter Contract for m/v Medusa With Cargill
Written by Customer Service on . Posted in Public Companies.
ATHENS, Greece, March 12, 2025 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that through a separate wholly-owned subsidiary, it has entered into a time charter contract with Cargill International SA, Geneva, for one of its Kamsarmax dry bulk vessels, the m/v Medusa. The gross charter rate is US$13,000 per day, minus a 4.75% commission paid to third parties, for a period until minimum May 15, 2026 up to maximum July 15, 2026. The charter is expected to commence on March 15, 2025.
The “Medusa” is an 82,194 dwt Kamsarmax dry bulk vessel built in 2010.
The employment of “Medusa” is anticipated to generate approximately US$5.46 million of gross revenue for the minimum scheduled period of the time...
Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering
Written by Customer Service on . Posted in Public Companies.
GAITHERSBURG, Md., March 12, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announced today the pricing of an underwritten public offering of 19,166,667 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price of $0.30 per share (the “Offering”). The aggregate gross proceeds to Shuttle Pharma from the Offering are expected to be approximately $5.75 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Shuttle Pharma. The Offering is expected to close on March 13, 2025, subject to the satisfaction of customary...
Coherent Launches Industry-First 793nm Pump Laser Diode with Record 28W Power and 97% Polarization Purity
Written by Customer Service on . Posted in Public Companies.
PITTSBURGH, March 12, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), the leader in advanced laser technology, is proud to announce the launch of its groundbreaking 793nm pump laser diode, setting a new industry standard with an impressive 28W of reliable power and 97% polarization purity. This innovative product offers unmatched performance and cost-efficiency, unlocking new possibilities for applications in the rapidly growing Thulium fiber laser market.
A Game-Changer in Thulium Fiber Laser TechnologyThe increasing adoption of Thulium fiber lasers in medical applications has transformed patient care, offering a safer, more comfortable treatment experience with faster recovery times. With the market for Thulium fiber lasers projected to grow significantly, the new 793nm chip from Coherent is poised to meet the growing demand...
Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial
Written by Customer Service on . Posted in Public Companies.
Encouraging Safety Profile Supports Progression Toward First Dual-Administration of Selective A2A and A2B Antagonists in Patients
DOVER, Del., March 12, 2025 (GLOBE NEWSWIRE) — Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of innovative therapeutics, today announced the resumption of patient enrollment in the fourth and final cohort of the dose escalation stage for PORT-6, a highly selective A2A antagonist, within its ADPORT-601 Phase 1b clinical trial. Portage had previously paused this trial due to funding concerns; this resumption of the trial underscores the encouraging findings observed in earlier cohorts. After the completion of the PORT-6 arm of the ADPORT-601 study, Portage will evaluate the continuation of the study into its PORT-7 (potent and...
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates
Written by Customer Service on . Posted in Public Companies.
GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, and Rocketvax Ltd, one of Switzerland’s next-generation vaccine companies and a member of the Swiss Rockets Ltd family of companies, today announced entry into an agreement for Emergent’s strategic financial investment into Swiss Rockets Ltd, the parent company of Rocketvax Ltd, to support research, infrastructure development, and the expansion of Swiss Rockets’ innovative biotechnology portfolio. This endeavor underscores Emergent’s commitment to supporting Swiss Rockets’ broader mission of pioneering breakthrough medical technologies.
In addition to the investment, the parties intend to form a strategic...
BEN Supports California’s AI Data Privacy Bill
Written by Customer Service on . Posted in Public Companies.
WILMINGTON, Del., March 12, 2025 (GLOBE NEWSWIRE) — Brand Engagement Network Inc. (BEN) (NASDAQ: BNAI), an innovator in AI-driven customer engagement solutions, has announced its support for California Assembly Member Carl DeMaio’s proposed AI data privacy legislation. This bill, which aims to secure the privacy of California residents, would require businesses to obtain explicit consent before sharing or storing user data outside the United States.
As AI adoption accelerates across industries, the need for robust data protection has never been more critical. BEN recognizes the importance of securing user data and supports DeMaio’s initiative as a vital step in advancing privacy protections in the AI space.
“Data privacy is a fundamental right, and it is crucial that we hold ourselves accountable in developing AI technologies,”...
Vera Bradley Announces Fourth Quarter Fiscal Year 2025 Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Consolidated net revenues totaled $372.0 million for the fiscal year
Financial condition remains strong with no debt and approximately $30 million in cash
Management provides guidance for fiscal year 2026
Outlook anticipates fiscal 2026 year-end cash balance increasing to approximately $40 million
FORT WAYNE, Ind., March 12, 2025 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) today announced its financial results for the fourth quarter and fiscal year ended February 1, 2025 (“Fiscal 2025”).
In this release, Vera Bradley, Inc. or “the Company” refers to the entire enterprise and includes both the Vera Bradley and Pura Vida brands. Vera Bradley on a stand-alone basis refers to the Vera Bradley brand.
Fourth Quarter and Fiscal Year-End Comments
Jackie Ardrey, Chief Executive Officer commented, “The fourth quarter...